Ignite Creation Date:
2025-12-24 @ 10:54 PM
Ignite Modification Date:
2026-05-29 @ 3:40 AM
Study NCT ID:
NCT00633269
Status:
COMPLETED
Last Update Posted:
2009-01-14
First Post:
2008-03-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours
Sponsor:
AstraZeneca
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
D0810C00010
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Jim Carmichael - CMO
Old Organization:
AstraZeneca
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |